To determine their capacity for tumor antigen presentation, IL-15 DCs were loaded by RNA electroporation with the WT1 tumor antigen [30] and examined for their ability to trigger IFN-γ production by a WT1126–134-specific CTL clone. The gene discussed is IL15; the disease is neoplasm.